Compare Two Stocks
Valuation, growth, earnings reaction and guidance credibility, side by sideVRTXVertex Pharmaceuticals
FinDog View：Bullish
| Metric | ABBV | VRTX |
|---|
| Close | 294.89 | 558.88 |
| Market Cap | $522B | $133B |
| 1M | +12.73% | +6.90% |
| P/E (TTM) | 81.4 | 30.6 |
| Forward P/E | 16.9 | 25.2 |
| P/E 5-Yr Percentile | 62 | 68 |
| P/S | 8.0 | 10.7 |
| P/B | — | 6.7 |
| Dividend Yield | 4.47% | — |
| Latest Quarter Revenue | $17.0B | $3.3B |
| Revenue YoY | +10.2% | +12.5% |
| Gross Margin | 74.7% | 85.3% |
| Latest Quarter EPS | 2.03 | 4.31 |
| Avg Post-Earnings Move | ±1.7% | ±6.7% |
| EPS Beat Rate | — | — |
| Guidance Hit Rate | — | — |
| Shareholder Yield | 2.58% | 1.51% |
| 90-Day Net Insider Buying | −$8.2M | — |
ABBV · Revenue, Last 8 Quarters ($B)
VRTX · Revenue, Last 8 Quarters ($B)
